8 results
Keyword Pegaptanib Remove keyword
Categories
Human Remove Human filter
Type of content
Events Remove Events filter
-
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 January 2014
European Medicines Agency, London, UK, from 06/01/2014 to 09/01/2014, Last updated: 13/08/2013 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 May 2014
European Medicines Agency, London, UK, from 05/05/2014 to 08/05/2014, Last updated: 13/08/2013 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 February 2016
European Medicines Agency, London, UK, from 08/02/2016 to 11/02/2016, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 January 2015
European Medicines Agency, London, UK, from 06/01/2015 to 09/01/2015, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 January 2013
European Medicines Agency, London, UK, from 07/01/2013 to 10/01/2013, Last updated: 02/06/2012 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 11-14 January 2016
European Medicines Agency, London, UK, from 11/01/2016 to 14/01/2016, Last updated: 13/03/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 18-21 October 2010
European Medicines Agency, London, UK, from 18/10/2010 to 21/10/2010, Last updated: 16/02/2010 -
List item
Committee for Medicinal Products for Human Use (CHMP): 18-21 July 2011
European Medicines Agency, London, UK, from 18/07/2011 to 21/07/2011, Last updated: 11/06/2010authorised medicine Macugen (pegaptanib sodium), 0.3 mg solution …